Loading clinical trials...
Loading clinical trials...
A Double-Blind, Cross-Over, Placebo- Controlled Efficacy and Tolerability Study of Oral Cannabidiol (CBD) and Tetrahydrocannabinol (THC) for Essential Tremor (ET).
Conditions
Interventions
CBD/THC
Placebo oral capsule
Locations
1
United States
University of California San Diego
La Jolla, California, United States
Start Date
January 22, 2019
Primary Completion Date
September 1, 2020
Completion Date
November 30, 2020
Last Updated
October 13, 2022
NCT07417280
NCT04212780
NCT03984643
NCT01581580
NCT07056361
NCT01734122
Lead Sponsor
University of California, San Diego
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions